RASGRP4 and rheumatoid arthritis: In experimental arthritis, RasGRP4-null mice did not develop K/BxN inflammatory arthritis and intra-articular injection of RasGRP4-specific siRNAs reduced the severity of the disease, suggesting that RasGRP4 is a potential target of therapy in RA [41].